ITC Asks for Comments on Omega-3 Extracts Patent Complaint
The International Trade Commission is asking for comments by Feb. 12 on public interest factors raised by Neptune Technologies & Bioresources and Acasti Pharma’s Jan. 29 Section 337 complaint against imports of omega-3 extracts by ten companies that allegedly infringe its patents. Neptune and Acasti are requesting limited exclusion and cease and desist orders against all respondents. Proposed respondents include:
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
- Aker BioMarine AS, Norway
- Aker BioMarine Antarctic USA, Inc.
- Aker BioMarine Antarctic AS, Norway
- Enzymotec Limited, Israel
- Enzymotec USA, INC.
- Olympic Seafood AS, Norway
- Olympic Biotec Ltd., New Zealand
- Avoca, Inc., U.S.
- Rimfrost USA, LLC., U.S.
- Bioriginal Food & Science Corp.
(See ITT’s Online Archives 13013131 for summary of the Section 337 complaint.)